Event context and recent share performance
Addus HomeCare (ADUS) has drawn attention after a recent share price pullback, with the stock showing negative returns over the past week, month, and past 3 months, and trading at US$95.19 at the last close.
See our latest analysis for Addus HomeCare.
The recent pullback fits into a wider trend, with a 1-year total shareholder return decline of 2.17% and a 3-year total shareholder return decline of 10.84%, suggesting momentum has been fading rather than building.
If recent weakness in Addus HomeCare has you reassessing opportunities in healthcare, this could be a useful moment to scan 34 healthcare AI stocks.
With the share price pulling back while Addus HomeCare reports annual revenue of US$1.42b and net income of US$95.91m, the key question is whether the current valuation reflects these fundamentals or if markets are already pricing in future growth.
Most Popular Narrative: 33.4% Undervalued
The most followed narrative values Addus HomeCare at $142.91 per share, well above the last close of $95.19, and ties that gap to long term earnings potential under a 6.78% discount rate.
Consistently strong organic growth in the core Personal Care segment, driven by robust hiring, technology enabled operations, and improving same store service volumes, positions Addus to further capitalize on the preference for aging in place and rising demand for home based care. This, in turn, boosts recurring revenue and operating leverage. Ongoing expansion through strategic acquisitions, focused on increasing geographic density and service overlap, should enable further cross sell opportunities and drive EPS accretion through revenue and cost synergies.
Want to understand why this valuation leans so heavily on recurring personal care revenue and future profit margins, not just headline growth? The full narrative unpacks how earnings, revenue mix, and the assumed valuation multiple all connect to that $142.91 fair value tag.
Result: Fair Value of $142.91 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, this depends on Medicaid and Medicare reimbursement remaining supportive, and on workforce and wage pressures not squeezing margins more than analysts currently assume.
Find out about the key risks to this Addus HomeCare narrative.
Next Steps
With sentiment clearly focused on whether the recent share pullback signals risk or upside, it helps to look past the headlines and test the numbers yourself. To see what investors view as the main positives before deciding how you feel about the stock, review the 5 key rewards.
Looking for more investment ideas?
If Addus HomeCare has sharpened your focus, do not stop here. Use the Simply Wall St tools to spot other opportunities that fit your style.
- Target rock solid balance sheets and steady fundamentals by scanning the solid balance sheet and fundamentals stocks screener (39 results).
- Hunt for potential value opportunities that combine quality and attractive pricing through the 61 high quality undervalued stocks.
- Spot lesser known companies with strong foundations before others catch on by checking the screener containing 26 high quality undiscovered gems.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com